Precision Medicine Initiative
Public Awareness of Personalized Medicine Not Growing in Step With Industry, Survey Shows
Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.
The Chinese government has implemented clearer regulatory guidance for genomic tests and invested in both clinical testing and research, spurring growth.
Geisinger Experience Implementing Precision Medicine Spurs New Effort to Help Others Do the Same
Premium
Geisinger is hoping to help others around the country implement precision medicine, which requires significant investment in genomics expertise, as well as infrastructural and operational changes.
The law contains provisions that proponents say will advance precision medicine and speed new tests to market, but critics worry if this will come at a cost to public health.
Despite Politics and Budget Limits, Precision Medicine Initiative 'Is Here to Stay,' Says Dishman
Premium
NIH has been conservative on the PMI's budget and its funds are sufficient to launch enrollment next year, begin collecting data, and initiate genetic testing pilot projects.